hepatitis drugs market analysis and demand by p&s market research

7/21/2019 Hepatitis Drugs Market Analysis and Demand by P&S Market Research

http://slidepdf.com/reader/full/hepatitis-drugs-market-analysis-and-demand-by-ps-market-research 1/10

Global Hepatitis Drugs Market Size, Share, Development,

Growth and Demand Forecast to 2020



© P&S Market Research. All rights reserved 2

Global Hepatitis Drugs Market Expected to Grow with 30% CAGR During 2015 –

2020

The global hepatitis drugs market was valued at $23,222.1 million in 2014, and it is expected to grow with a

CAGR of 29.7% during 2015 - 2020. The global hepatitis drugs market is growing due to increasing incidences of

hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and

increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the globalhepatitis drugs market.

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness

the fastest growth during the forecast period, with a CAGR of 30.7%.

Explore Report w ith Detailed TOC on “ Global Hepatitis Drugs Market” at:

https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market

The information and data in the publication “Global Hepatitis Drugs Market Size, Share, Development, Grow th

and Demand Forecast to 2020” represent the research and analysis of data from various primary and secondarysources. The bottom-top approach has been used to calculate the global market size by type and drugs. The

market numbers for countries are obtained through top-down approach. P&S Market Research analysts and

consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every

value of data presented in this report. The company bases its primary research on discussions with prominent

professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

Ask fo r Sample Pages : https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market/report-

sample

TABLE OF CONTENT

Chapter 1. Research Scope & Methodology

1.1 Market Definition

1.2 Objective

1.3 Market Scope

1.3.1 Market breakdown by segment

1.3.2 Market breakdown by geography

1.4 Research Methodology and Sources






https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market/report-sample










2020

Chapter 2. Executiv e Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Global Trend in Hepatitis Drugs Market

3.2.1 Increasing number of collaborations and partnerships

3.3 Factors Driving the Growth of the Market and its Impact on Market Forecast

3.3.1 Increasing incidences of hepatitis

3.3.2 Increasing support from government organizations

3.3.3 Growing geriatric population

3.3.4 Increasing R&D investments in hepatitis research and drug discovery

3.3.5 Impact analysis of drivers on market forecast

3.4 Factors Hindering the Market and its Impact on Market Forecast

3.4.1 High capital expenditure

3.4.2 Stringent regulatory requirements

3.4.3 Impact analysis of restraints on market forecast

Chapter 4. Global Hepatit is Drugs Market Size and Forecast (2011 – 2020)

4.1 Global Hepatitis Drugs Market Breakdown by Type

4.2 Global Hepatitis Drugs Market Breakdown by Geography

Chapter 5. Global Hepatiti s Drugs Market Breakdown by Type

5.1 Hepatitis C Drugs Market

5.1.1 Hepatitis C drugs market segmentation by region

5.1.2 Hepatitis C drugs market segmentation by drugs





2020

5.2 Hepatitis B Drugs Market

5.2.1 Hepatitis B drugs market segmentation by region

5.2.2 Hepatitis B drugs market segmentation by drugs

5.3 Hepatitis A Drugs Market

5.3.1 Hepatitis A drugs market segmentation by region

Chapter 6. Global Hepatiti s Drugs Market Breakdown by Geography

6.1 North America Hepatitis Drugs Market

6.1.1 North America hepatitis drugs market breakdown by type

6.1.2 North America hepatitis drugs market breakdown by country

6.2 Europe Hepatitis Drugs Market

6.2.1 Europe hepatitis drugs market breakdown by type

6.2.2 Europe hepatitis drugs market breakdown by country

6.3 Asia Hepatitis Drugs Market

6.3.1 Asia hepatitis drugs market breakdown by type

6.3.2 Asia hepatitis drugs market breakdown by country

6.4 Rest of the World Hepatitis Drugs Market

6.4.1 RoW hepatitis drugs market breakdown by type

Chapter 7. Pipeline Drugs for Hepatitis

Chapter 8. Drug Approval Process in the .S. and EU

8.1 Drug approval process in the U.S.

8.2 Drug Approval in the EU

Chapter 9. Competitive Positioning and Market Share Analysis

9.1 Porter's Five Forces of Competitive Position Analysis

9.1.1 Bargaining power of buyers





2020

9.1.2 Bargaining power of suppliers

9.1.3 Threat of new entrants

9.1.4 Intensity of rivalry

9.1.5 Threat of substitutes

9.2 Global Hepatitis Drugs Market Share Analysis

Chapter 10. Company Profil es and Strategic Developments

10.1 Key Company Profiles

10.1.1 Gilead Sciences Inc.

10.1.1.1 Business overview

10.1.1.2 Product and service offerings

10.1.2 F. Hoffmann-La Roche Ltd



10.1.3 Johnson & Johnson


10.1.3.2 Product and services offerings

10.1.4 Merck & Co., Inc.



10.1.5 GlaxoSmithKline plc



10.1.6 AbbVie Inc.






2020


10.1.7 Novartis AG



10.1.8 Bristol-Myers Squibb Company



10.1.9 Dynavax Technologies Corporation



10.1.10 Mitsubishi Tanabe Pharma Corporation



10.2 Strategic Developments in the Hepatitis Drugs Market

10.2.1 Mergers & acquisitions

10.2.2 Collaborations & partnerships

10.2.3 Marketing authorization

10.2.4 Product launch

10.2.5 Application filling

10.2.6 Pipeline newscast

10.2.7 Others

Chapter 11. Appendix

11.1 List of Abbreviations





2020

Buy Report at: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market

LIST OF TABLES

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2 GLOBAL HEPATITIS DRUGS MARKET SNAPSHOT

TABLE 3 MAJOR COLLABORATION AND PARTNERSHIPS IN HEPATITIS DRUGS MARKET (2015)

TABLE 4 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6 GLOBAL HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 7 GLOBAL HEPATITIS DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 8 GLOBAL HEPATITIS C DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 9 GLOBAL HEPATITIS C DRUGS MARKET BREAKDOWN BY DRUGS, $M (2015–2020)

TABLE 10 GLOBAL HEPATITIS B DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 11 GLOBAL HEPATITIS B DRUGS MARKET BREAKDOWN BY DRUGS, $M (2015 – 2020)

TABLE 12 GLOBAL HEPATITIS A DRUGS MARKET BREAKDOWN BY GEOGRAPHY, $M (2015 – 2020)

TABLE 13 NORTH AMERICA HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 14 NORTH AMERICA HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 –2020)

TABLE 15 EUROPE HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 16 EUROPE HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 17 ASIA HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 18 ASIA HEPATITIS DRUGS MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 19 ROW HEPATITIS DRUGS MARKET BREAKDOWN BY TYPE, $M (2015 – 2020)

TABLE 20 DRUGS UNDER DEVELOPMENT FOR CHRONIC HEPATITIS B, 2015

TABLE 21 CLINICAL TRIAL STAGES OF HEPATITIS C DRUGS, 2015









2020

TABLE 22 GILEAD SCIENCES INC.– KEY FACTS

TABLE 23 F. HOFFMANN-LA ROCHE LTD – KEY FACTS

TABLE 24 JOHNSON & JOHNSON – KEY FACTS

TABLE 25 MERCK & CO., INC. – KEY FACTS

TABLE 26 GLAXOSMITHKLINE PLC – KEY FACTS

TABLE 27 ABBVIE INC. – KEY FACTS

TABLE 28 NOVARTIS AG – KEY FACTS

TABLE 29 BRISTOL-MYERS SQUIBB COMPANY – KEY FACTS

TABLE 30 DYNAVAX TECHNOLOGIES CORPORATION KEY FACTS

TABLE 31 MITSUBISHI TANABE PHARMA CORPORATION - KEY FACTS

Buy Report at: https://www.psmarketresearch.com/market-analysis/-hepatitis-drugs-market

LIST OF FIGURES

FIG 1 RESEARCH SCOPE FOR GLOBAL HEPATITIS DRUGS MARKET

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL HEPATITIS DRUGS MARKET

FIG 3 TYPES OF HEPATITIS

FIG 4 MAJOR SYMPTOMS OF HEPATITIS

FIG 5 DIAGNOTSIC PROCEDURES FOR HEPATITIS

FIG 6 KEY DRUGS USED TO TREAT HEPATITIS B AND HEPATITIS C

FIG 7 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION IN MAJOR COUNTRIES

FIG 8 BASIC DRUG DEVELOPMENT PROCEDURE

FIG 9 GLOBAL HEPATITIS DRUGS MARKET SIZE BY TYPE, $M (2014 – 2020)

FIG 10 GLOBAL HEPATITIS DRUGS MARKET SIZE BY GEOGRAPHY, $M (2014 – 2020)









2020

FIG 11 GLOBAL HEPATITIS C DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 12 GLOBAL HEPATITIS C DRUGS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 13 GLOBAL HEPATITIS C DRUGS MARKET SIZE BY REGION, $M (2014 – 2020)

FIG 14 GLOBAL HEPATITIS C DRUGS MARKET SIZE BY DRUGS, $M (2014 – 2020)

FIG 15 GLOBAL HEPATITIS B DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 16 GLOBAL HEPATITIS B DRUGS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 17 GLOBAL HEPATITIS B DRUGS MARKET SIZE BY REGION, $M (2014 – 2020)

FIG 18 GLOBAL HEPATITIS B DRUGS MARKET SIZE BY DRUGS, $M (2014 – 2020)

FIG 19 GLOBAL HEPATITIS A DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 20 GLOBAL HEPATITIS A DRUGS MARKET SHARE, BY REGION (2014 AND 2020)

FIG 21 GLOBAL HEPATITIS A DRUGS MARKET SIZE BY REGION, $M (2014 – 2020)

FIG 22 GLOBAL HEPATITIS DRUGS MARKET SIZE, BY GEOGRAPHY

FIG 23 NORTH AMERICA HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 24 NORTH AMERICA HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 25 NORTH AMERICA HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 26 EUROPE HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 27 EUROPE HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 28 EUROPE HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 29 ASIA HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 30 ASIA HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 31 ASIA HEPATITIS DRUGS MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 32 ROW HEPATITIS DRUGS MARKET SIZE, $M (2014 – 2020)

FIG 33 ROW HEPATITIS DRUGS MARKET SHARE, BY TYPE (2014 AND 2020)

FIG 34 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS





2020

FIG 35 MARKET SHARE OF KEY PLAYERS IN THE GLOBAL HEPATITIS DRUGS MARKET (2014)

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for

various geographies around the globe. We provide market research reports, industry forecasting reports,

business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate

forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through

their interaction with leading companies of the concerned domain. We help our clients with B2B market research

and assist them in identifying various windows of opportunity, and framing informed and customized businessexpansion strategies in different regions.

Contact:

Ms Abhishek

Executive – Client Partner

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected] Web: https://www.psmarketresearch.com

https://www.psmarketresearch.com/




hepatitis drugs market analysis and demand by p&s market research

Documents